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Abstract. There are two clathrin-coated vesicle adap- 
tor complexes in the cell, one associated with the 
plasma membrane and one associated with the TGN. 
The subunit composition of the plasma membrane 
adaptor complex is a-adaptin, 13-adaptin, AP50, and 
AP17; while that of the TGN adaptor complex is 
7-adaptin, [3'-adaptin, AP47, and AP19. To search for 
adaptor targeting signals, we have constructed chimeras 
between oL-adaptin and ~/-adaptin within their NH2-ter- 
minal domains. We have identified stretches of se- 
quence in the two proteins between amino acids ~130 
and 330-350 that are essential for targeting. Immuno- 
precipitation reveals that this region determines 
whether a construct coassembles with AP50 and AP17, 
or with AP47 and AP19. These observations suggest 
that these other subunits may play an important role in 
targeting. In contrast, 13- and [3'-adaptins are clearly not 
involved in this event. Chimeras between the a- and 
7-adaptin COOH-terminal domains reveal the pres- 
ence of a second targeting signal. We have further in- 
vestigated the interactions between the adaptor sub- 
units using the yeast two-hybrid system. Interactions 
can be detected between the 13/13'-adaptins and the 
a/7-adaptins, between the [3/[3'-adaptins and the AP50/ 
AP47 subunits, between ot-adaptin and AP17, and be- 
tween 7-adaptin and AP19. These results indicate that 
the adaptor subunits act in concert to target the com- 
plex to the appropriate membrane. 
C  LATHRIN-COated pits  and  vesicles  bud  from  two 
membrane compartments of the cell: the plasma 
membrane  and  the  TGN.  Although  the  clathrin 
associated  with  these  two  membranes  is  the  same,  the 
adaptor complexes, which attach the clathrin to the mem- 
brane, are  different (Robinson,  1987;  Ahle  et al.,  1988). 
There is some evidence that the adaptors bind to the cyto- 
plasmic domains of selected membrane proteins (e.g., the 
receptors for LDL, transferrin,  and  EGF at  the  plasma 
membrane; and the mannose-6-phosphate receptor at the 
TGN)  (Pearse,  1988;  Glickman  et  al.,  1989;  Sorkin  and 
Carpenter,  1993;  Sorkin  et  al.,  1995;  Sosa  et  al.,  1993), 
causing such proteins to become concentrated in coated 
pits  and  vesicles for transport  to another compartment. 
However, it seems unlikely that these interactions are re- 
sponsible for targeting the adaptors to the plasma mem- 
brane or the TGN, since proteins such as the transferrin 
receptor are often found at higher concentrations in endo- 
somal compartments where adaptors are absent. Thus, it 
has been proposed that adaptors are recruited onto the ap- 
propriate membrane by interacting with specific adaptor 
docking proteins (Robinson, 1993; Traub ct al.,  1993). Al- 
though these docking proteins have yet to be identified, 
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they presumably act by recognizing targeting  signals  on 
the two adaptor complexes. 
Both adaptor complexes are heterotetramers, consisting 
of two  100-kD subunits  or adaptins,  a  medium chain of 
~50 kD, and a small chain of ~20 kD. The plasma mem- 
brane adaptor complex is composed of a-adaptin, 13-adap- 
tin, AP50, and AP17, while the TGN adaptor complex is 
composed  of  7-adaptin,  13'-adaptin,  AP47,  and  AP19 
(Keen, 1987; Ahle et al., 1988).  Rotary shadowing of iso- 
lated adaptors shows that they consist of a brick-like core 
or "head" attached to two smaller appendages or "ears" 
by stalks that are thought to act as flexible hinges (Heuser 
and Keen, 1988). The ears correspond to the COOH-ter- 
minal domain of the two adaptins, while the head consists 
of the NH2-terminal domains of the adaptins together with 
the medium  and small chains  (Kirchhausen et al.,  1989) 
(see the model in Fig. 1). But although the general organi- 
zation of the complex is known, there is little information 
on exactly how the  adaptor  subunits  interact with  each 
other, or on what the function of each domain or subunit 
is. It is not known, for example, which part of the complex 
is  responsible  for  targeting  the  adaptor  to  the  correct 
membrane compartment. 
It  seems  unlikely that  the  13-  and  13'-adaptins  are  in- 
volved in adaptor targeting for several reasons. They are 
the most homologous of the four subunits (Kirchhausen et 
al.,  1989;  Ponnambalam  et al.,  1990); they have  already 
been assigned a role in clathrin binding (Ahle and Unger- 
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idge  and  Pearse  (1994)  have  recently  shown  that  when 
Drosophila 13-adaptin (which shows homology to both 13- and 
13'-adaptins) is transfected into mammalian cells, it local- 
izes to both the TGN and the plasma membrane and as- 
sembles with both ~- and ~-adaptin. The ~- and ~/-adaptins 
are better candidates for proteins containing targeting sig- 
nals  because  they are  the  least  homologous of the  four 
subunits,  and  their  ear  domains  in  particular  are  com- 
pletely unrelated (Robinson, 1990).  In an earlier study we 
investigated the possibility that the tx- and ~/-adaptin ears 
might be responsible for targeting by constructing chime- 
ras. A  chimera consisting of the c~-adaptin NH2-terminal 
domain, the "y-adaptin hinge, and the ~/-adaptin ear (coy-c) 
was found to be localized to the plasma membrane (Rob- 
inson,  1993), suggesting that the -/-adaptin ear domain is 
not involved in targeting.  However, a chimera consisting 
of  the  "y-adaptin  NH2-terminal  domain,  the  ~/-adaptin 
hinge, and the ~x-adaptin ear (-/~/c~) was found to be mainly 
associated with the TGN, but in some cells a  fraction of 
the  construct  was  localized  to  the  plasma  membrane. 
These results suggested that the ear may play a minor role 
in targeting, but that the major targeting signal is likely to 
be present in the adaptor head. Thus, any of the subunits 
with the possible exception of 13/f3' could potentially be in- 
volved in adaptor localization. 
The  aim of the  present study was to determine  which 
part of the complex is responsible for targeting by making 
chimeras  between  the  NH2-terminal  domains  of c~-  and 
"¢-adaptin. Although  there is no reason necessarily to as- 
sume that these domains contain the adaptor targeting sig- 
nals,  their  localization  within  the  complex suggests  that 
they interact with the other adaptor subunits,  and there- 
fore the prediction was that some of the chimeras should 
assemble into complexes containing  a  mixture of plasma 
membrane  and  TGN  adaptor  subunits.  Thus,  this  ap- 
proach should  allow us to test whether  targeting can be 
correlated  with  the  presence  or  absence  of a  particular 
subunit,  while  at  the  same  time  providing  information 
about how the subunits interact with each other. 
Materials and Methods 
Construction  of Plasmids 
The adaptins have three domains: NHz-terminal (head), hinge, and ear. 
The NHz-terminal domain is defined as amino acids  1~519 in a-adaptin 
and  1-593  in -¢-adaptin;  the hinge is defined  as amino acids  620-700  in 
c~-adaptin and 594-703  in "y-adaptin; and  the ear domain is defined  as 
amino acids 701-938  in c~-adaptin and 704-822  in ~/-adaptin  (see Robin- 
son, 1989, 1993). 
Most of the constructs that were made contain the u-adaptin ear, and 
all have the bovine ~/-adaptin hinge, which is required for recognition by 
the  species-specific  antibody mAb 100/3. The basic techniques used in 
making the constructs are described by Sambrook et al. (1989). The gen- 
eral strategy was first to identify stretches of identical  or highly conserved 
protein sequence in the  NH2-terminal domain where ~- and  ~,-adaptin 
could be joined together. A  naturally occurring restriction site  was then 
sought in one DNA sequence and PCR was used to introduce the same 
site, in frame, into the other sequence. For example, N~/-331 (the nomen- 
clature refers to the NH2-terminal domain having -,/-adaptin sequence up 
to amino acid  residue 331) was made by introducing an ApaLI site  into 
~,-adaptin by PCR in the middle of a sequence that is conserved between 
the two adaptins. The c~-adaptin naturally contains this restriction site so a 
three-way ligation  of the  following was performed: the -~-adaptin  PCR 
product digested with NotI at the 5' end and ApaLI at the 3' end (to give 
the first half of the chimera's NH2-terminal sequence), ct-adaptin  digested 
with ApaLI and ApaI (to provide the rest of the NH2-terminal sequence), 
and the expression vector encoding a~/a  (Robinson, 1993) cut with NotI 
and ApaI (which releases the NH2-terminal domain of the construct, leav- 
ing the vector plus the bovine ~/-adaptin hinge and a-adaptin ear). The di- 
gests were run on an agarose gel, the appropriate bands were isolated,  the 
DNA was extracted using a Geneclean kit (BIO 101, Inc., Vista, CA), and 
the fragments were ligated together. In some cases no natural site could 
be exploited so restriction sites were introduced by PCR  into both se- 
quences. All of the joins between u- and 3,-adaptin sequences and much of 
the PCR products were sequenced. 
The following chimeras were constructed  (see  Fig.  2):  N~/-36: intro- 
duced a SnaBI site into both sequences; N~/-132: made use of the BanlI 
site in ~-adaptin; N3,-190: made use of the NcoI site in ~-adaptin; N~,-331: 
made use of the ApaLI site in a-adaptin; N'y-566: made use of the Sacl site 
in 3,-adaptin;  N~-132:  made  use of the  NheI site  in "y-adaptin; Na-171: 
made use of the DraltI site in cc-adaptin; Na-265:  made use of the HindlII 
site in tx-adaptin; Ntx-350: introduced an EcoRV site into both sequences; 
Na-430:  made use of the BglI site in a-adaptin; N~-566: made use of the 
SacI site in ~-adaptin. 
Since  alignment of the two sequences results in several gaps, the no- 
menclature does not always reflect the relationship between chimeras of 
the  different  series.  For  example,  3,-adaptin  residue  330  aligns  with 
a-adaptin residue 350  (for alignment see Robinson, 1990), so that con- 
structs N'~-331 and Na-350 are actually  joined within the same conserved 
stretch of sequence, but one consists of ~/followed by c~ while the other 
consists of c~ followed by ~,. 
All of the chimeras were made using DNA from constructs c~/a  and 
V~a  in the expression vector pHYKS3 (Robinson, 1993). However, be- 
cause the NH2-terminal domain of the original ~-,/ct construct was a chi- 
mera between mouse and cow, this construct was modified to obtain an 
NH2-terminal ~/-adaptin  sequence entirely  derived  from mouse using a 
similar strategy to that already described, making use of Notl, SacI,  and 
ApaI sites.  This facilitated  the construction of other chimeras as the bo- 
vine NH2-terminal domain has not been entirely sequenced. 
The ear swap constructs were made by digesting ~/~¢ with Notl and 
ApaI to obtain an expression vector containing the hinge and ear domains 
only. The appropriate plasmid was digested with the same enzymes but in 
this case the NH:-terminal domain was isolated and ligated  into the cut 
vector. 
Transfection  into Rat 1 Cells 
Rat 1 fibroblasts maintained in DME containing 10%  FCS (DME-FCS) 
were cotransfected with the  various constructs and the  G418-selectable 
plasmid pRSVneo (Robinson, 1993) using one of the following protocols: 
(a)  the  calcium  phosphate method  as previously described  (Robinson, 
1990). (b) The DEAE Dextran method. Cells were grown in 25-cm 2  flasks 
and washed in DME, and ~5 ~g of construct DNA plus 1 Ixg of pRSVneo 
in 0.5 ml of DME was added, followed by 0.5 ml of 1 mg/ml DEAE Dex- 
tran in TBS, pH 7.4. The cells were then incubated for 30 minutes at 37°C, 
after which the medium was replaced with DME-FCS containing 0.1 mg/ 
ml chloroquine, and the cells were incubated in this solution for 3 hours at 
37°C. The cells were then washed in DME-FCS and incubated overnight. 
(c)  Transfectam (Promega Corp., Madison WI). Cells  grown in 25-cm 2 
flasks  were washed and incubated in 0.5  ml DME.  A  solution of 10  ixl 
Transfectam in 0.5 ml DME and a solution of DNA (5 ~g of construct plus 
1 /~g of pRSVneo) in 0.5 ml DME were mixed together and added to the 
ceUs, which were then incubated overnight at 37°C. 
In all procedures the cells were trypsinized the next day and split into 3 
dishes.  They were left for two more days before G418  was added to the 
medium at a  concentration of 0.5  mg/ml. After 2 wk, individual  G418- 
resistant colonies were picked with a sterile  yellow tip and transferred to a 
multiwell plate. Expression of the chimeras was assayed by immunofluo- 
rescence. Even after two rounds of cloning,  some of the cell lines showed 
heterogeneity in their expression levels. 
Immunofluorescence 
Ceils  grown on multiwell slides  were fixed  in methanol and acetone as 
previously described (Robinson, 1990). Immunofluorescence was carried 
out using the mouse antibody mAb 100/3 (Ahle et al., 1988) which recog- 
nizes  the bovine but not the rat ~/-adaptin  hinge. For some experiments 
the ceils  were double labeled either with the rabbit antibody C619-656, 
raised to the aC-adaptin hinge (amino acids 619~556) (Ball et al., 1995) or 
with an antibody raised against a  13-adaptin fusion protein (see below). 
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and examination of the slides were  carried  out as previously described 
(Robinson, 1990). 
Production of Monospecific Antibodies 
To identify the adaptor subunits that coassemble with the various con- 
structs, monospecific antibodies were  raised.  First,  DNA  encoding the 
subunits was amplified from rat liver cDNA (Clontech) by PCR and li- 
gated into pBluescript, and the identity of the clones was confirmed by se- 
quencing. A  second PCR reaction was then used to amplify specific se- 
quences and to introduce restriction sites compatible with pGEX3X. The 
sequences that were amplified encoded: amino acids 583~519 for 13-adap  - 
tin; amino acids 583~619 for I~'-adaptin; amino acids 16-78 and 278-384 
for AP50 (AP50-1 and AP50-2); amino acids 17-80 and 268-374 for AP47 
(AP47-1 and AP47-2); amino acids 20-61  and 107-142 for AP17 (AP17-1 
and AP17-2); and amino acids 20451  and 107-158 for AP19 (AP19-1 and 
AP19-2). These sequences were chosen because they are where the two 
homologues show the most divergence  (Kirchhausen et al.,  1989,  1991; 
Ponnambalam et  al.,  1990;  Nakayama et  al.,  1991).  The PCR products 
were ligated into pGEX3X and transformed into MC1060 host cells for se- 
quencing and expression. Of the ten fusion proteins, only the t3 and ~3' 
constructs and AP19-2 were found to be soluble, and these were purified 
on GSH-Sepharose (Pharmacia LKB Biotechnology Inc., Piscataway, N J) 
according to the manufacturer's instructions~ To purify the other seven fu- 
sion proteins, inclusion bodies were prepared (Bohmann and Tijian, 1989) 
and the proteins solubilized in sample buffer and subjected to preparative 
SDS PAGE. Up to 5 mg purified protein was obtained from each 100-ml 
culture.  Rabbits  were  injected  with  0.5  mg fusion protein in complete 
Freund's adjuvant, followed by boosts of 0.5 mg fusion protein in incom- 
plete Freund's adjuvant at 2 and 8 wk after the primary injection. 10 d af- 
ter the final injection, the rabbits were bled out and their sera tested on 
blots of purified adaptors. 7 of the 10 fusion proteins elicited a response 
against the appropriate adaptor subunit (the ones that did not were AP50- 
1, AP17-1, and AP19-1, and these were discarded). To ensure that the an- 
tibodies  would  be  monospecific, and  to  improve  the  signal relative  to 
background, the seven positive antisera were cross-absorbed and affinity 
purified. Each fusion protein was coupled to CNBr-activated Sepharose 
(Pharmacia), and 20 ml of each serum were absorbed over two nights at 
4°C with resin containing 0.67 mg of the "wrong" fusion protein (e.g., anti- 
13 was absorbed with [3' and vice versa). The resin was then removed by 
centrifugation, and the sera were  absorbed overnight at 4°C with  resin 
containing 0.33 mg of the "right" fusion protein. Bound antibodies were 
eluted  with  0.2  M  gly,  pH  2.3,  as previously described  (Robinson and 
Pearse, 1986). 
Immunoprecipitation and Western Blotting 
The immunoprecipitation protocol was based on a method developed by 
B. Pearse that has previously been described (Robinson, 1993). Cells were 
lysed with 1% NP-40 and centrifuged at high speed to obtain a membrane 
pellet enriched in assembled adaptor complexes. The pellet was then ex- 
tracted with 0.05M Na2CO3 to solubilize the membrane-associated adap- 
tors, which were then immunoprecipitated using mAbl00/3, followed by 
rabbit  anti-mouse IgG  (Sigma  Immunochemicals, St.  Louis, MO)  and 
protein A-Sepharose 4BFast (Sigma). After extensive washing (see Rob- 
inson, 1993),  the pellets were  resuspended in 2×  sample buffer, boiled, 
and subjected to SDS PAGE. Gels were blotted onto nitrocellulose and 
labeled with the antibodies raised against the various adaptor subunits, 
followed by 125I-protein A  (Amersham Corp., Arlington Heights, IL). For 
maximum resolution, the x-ray film was exposed at  room temperature 
without an intensifying screen. 
Yeast Two-Hybrid System 
The  "Matchmaker"  two-hybrid  system was  obtained  from  CIonetech 
Labs. (Palo Alto, CA) and all procedures were carried out as described in 
the manufacturer's instructions. PCR was used to generate appropriate re- 
striction sites in the adaptor subunit cDNAs (some of which were gener- 
ously provided  by T. Kirchhausen) for  expression in  the yeast vectors 
pGBT9 and pGAD424. The yeast strain SFY526 was cotransformed with 
the plasmids using a  PEG/lithium acetate protocol  and grown on plates 
lacking in leucine and tryptophan to select for colonies containing both 
plasmids. The colonies were transferred onto filter paper and permeabi- 
lized by freezing in liquid nitrogen and thawing at room temperature. The 
filters were then placed on another piece of filter paper that had been pre- 
soaked in a solution containing 0.33 mg/ml X-gal and were incubated at 
30°C until the color developed. 
13-Galactosidase activity was also measured using a liquid culture assay 
that makes use of the substrate ONPG and measures the release of o-ni- 
trophenol. Cells were grown at 30°C in media lacking in tryptophan and 
leucine to an OD of ~1.0, and aliquots were permeabilized by the addi- 
tion of chloroform and SDS 0.16 ml of o-nitrophenylgalactoside (4 mg/ml) 
was added,  and the tubes were incubated at 30°C until the color devel- 
oped. The reactions were quenched by the addition of 0.4 ml 1 M Na2CO3 
and their absorbance at 420 nm was measured. One unit of activity was 
defined as OD420 divided by (OD600 ×  ml ×  min) ×  1,000. 
Results 
Localization of the N7 Constructs 
To investigate the role of the et- and ~/-adaptin NH2-termi- 
nal  domains  in  adaptor  targeting,  chimeras  were  con- 
structed within  this  region, joining the  two  adaptins  to- 
gether at points where they show the most homology (Fig. 
2). Constructs in the N'y series (a) all have NH2-terminal 
domains  consisting  of  "y-adaptin  sequence  followed  by 
a-adaptin sequence, while constructs in the Na series (b) 
all have NH2-terminal domains consisting of et-adaptin se- 
quence followed by ~/-adaptin sequence. This is then fol- 
lowed  by the  bovine ~/-adaptin  hinge,  which  allows  the 
constructs to be detected by the species-specific antibody, 
mAb 100/3. Most of the constructs end with the et-adaptin 
ear. The constructs were stably transfected into Rat 1 cells 
and localized by immunofluorescence. Fig. 3 shows the lo- 
calization of the constructs in the N~/series. 
N'y-36 (Fig. 3 a) and N'¢-132  (b) both show a punctate 
pattern  characteristic  of plasma  membrane  coated  pits. 
Double labeling with an antibody specific for the a-adaptin 
hinge (Ball et al., 1995) reveals that the constructs colocal- 
ize with endogenous a-adaptin (d and e). There is however 
some cytoplasmic staining as well, and this is observed for 
most of the NH2-terminal domain chimeras. The next con- 
struct in the series, N-,/-190 (c), is not recruited to either 
the plasma membrane or the TGN but has an exclusively 
cytoplasmic distribution, suggesting that the targeting sig- 
nal  may  have  been  disrupted.  N-,/-331 (g)  is  localized 
mainly to a perinuclear compartment, shown by double la- 
beling with anti-TGN38 (Luzio et al., 1990) to be the TGN 
(not shown).  However, some plasma  membrane recruit- 
ment can also be seen (g and i, arrowheads). This varied in 
intensity from cell  to  cell but generally appeared  to  be 
Figure 1.  Schematic diagram of the two adaptor complexes. The 
heads consist of the NH2-terminal domains of the adaptins (~ and 
13 in the plasma membrane adaptor complex; ~ and [3' in the TGN 
adaptor complex), plus the medium chains (AP50 or AP47) and 
the small chains (AP17 or AP19). The COOH-terminal  domains 
of the adaptins form the ears, which are connected to the head by 
flexible hinges. 
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structs  in the N~  series  (a) contain  "y-adaptin sequence  at the 
NH2-terminal end followed by a-adaptin sequence.  The nomen- 
clature  refers to the protein at the NHz-terminal  end and to the 
amino acid where the join was made. Constructs  in the Nct series 
(b) contain ~x-adaptin  sequence at the NHz-terminal end followed 
by ~-adaptin sequence. Two previously described constructs, a-y~x 
and ~p/et (Robinson,  1993), are also shown. All of the constructs 
contain the bovine ~-adaptin hinge. The constructs in (a) and (b) 
all have the ct-adaptin ear, while those in (c) were made with the 
"v-adaptin ear. 
stronger than that observed for the chimera ~/~/tx (see Rob- 
inson, 1993). The last construct in the series, N'y-566, is lo- 
calized mainly to the TGN (h) and looks similar in its dis- 
tribution to ~/~ct. 
Assembly of the N y Constructs 
The immunofluorescence results suggest that  a  targeting 
signal may exist in the ~- and 7-adaptins somewhere be- 
tween  amino  acids  132  and  331.  However,  the  ct-  and 
~/-adaptins are part of a complex, and an alternative expla- 
nation is that this stretch of sequence may be indirectly in- 
volved in targeting by binding to one or more of the other 
adaptor  subunits.  Thus,  we  carried  out  studies  to  deter- 
mine whether there was any correlation between targeting 
and the presence of a particular subunit. For these experi- 
ments it was essential to be able to identify the other sub- 
units unambiguously.  To date,  no antibodies against the 
medium  and  small  chains  have  been  described,  and  the 
two  antibodies  available  that  recognize  the  [3  subunits 
cross-react with both [3-adaptin and 13'-adaptin (Robinson, 
1987; Ahle et al., 1988).  In order to raise specific antibod- 
ies against each of the subunits, GST fusion proteins were 
constructed containing unique regions of 13-adaptin,  AP50, 
AP17,  13'-adaptin, AP47, and AP19, and were used to im- 
munize rabbits. The resulting antisera were tested on blots 
of purified plasma membrane and TGN adaptors.  Fig.  4 
shows that all six of the antibodies only recognize the sub- 
unit against which they were raised and do not cross-react 
with the homologous protein in the other complex. 
To examine the composition of the adaptor complexes 
assembled  from  the  chimeric  adaptins,  mAb  100/3  was 
used to immunoprecipitate each construct plus associated 
proteins from a  carbonate-extracted high speed pellet of 
detergent-lysed transfected cells.  Similar immunoprecipi- 
tates were prepared from cells expressing the  constructs 
a~/a  and  "y"~x, and  from nontransfected  Rat  1 cells.  The 
samples were subjected to SDS PAGE, blotted, and probed 
with  antibodies  against the  plasma membrane and  TGN 
adaptor subunits (Fig. 5). The antibodies against the adap- 
tor medium chains produced some background labeling of 
the immunoglobulin heavy chain band, which can be seen 
in  the  control  immunoprecipitates  from  the  nontrans- 
fected  ceils  as  well  as  in  the  immunoprecipitates  of the 
constructs. However, the specifically labeled adaptor me- 
dium chains can be clearly resolved from the immunoglob- 
ulin band: they run as much sharper bands just below it. 
The  et~/ct construct  has  been  shown  to  localize  to  the 
plasma membrane  (Robinson,  1993),  and  Fig.  5  demon- 
strates that this construct associates with the plasma mem- 
brane adaptor subunits [3, AP50, and AP17, although there 
is also a  small amount of 13'-adaptin present.  Complexes 
containing the chimeras N~/-36 and N7-132, which are also 
targeted to the plasma membrane, were also found to con- 
tain 13, AP50, and AP17. They, too, therefore associate with 
the  subunits  normally  found  in  the  plasma  membrane 
adaptor complex. No other subunits could be detected in 
immunoprecipitates of N~/-190; however, because this con- 
struct was found to be present in the high speed pellet in 
very small amounts, it is possible that the antibodies were 
not sensitive enough to detect them. The next two chime- 
ras in the series, N~/-331 and N~-566, were found to be as- 
sociated with 13, AP47,  and AP19.  A  small amount of 13' 
could  also  be  detected,  suggesting  that  both  13-  and  13'- 
adaptin can associate with these two chimeras. However, 
they appear to assemble preferentially with 13-adaptin even 
though they are recruited to the TGN. A  similar pattern 
was seen with the construct N~-331~ (see below). The ~p/et 
construct, which is targeted to the TGN (Robinson, 1993), 
associates with the normal subunits for the TGN adaptor 
complex,  13'-adaptin,  AP47,  and  AP19,  although  again 
some heterogeneity is observed for the  13/13' subunits as 
there is a small amount of 13-adaptin also present. 
These results show a  correlation between the presence 
of a particular medium and small chain and the targeting 
of the  complex to  a  particular  membrane. However, no 
correlation is seen for  13- and  [3'-adaptin, indicating  that 
the  13 subunits are not involved in this event. The results 
also show that unlike the medium and small chains, [3- and 
13'-adaptins behave somewhat promiscuously: although all 
of the  constructs  appear to  assemble preferentially with 
one of the two  13 subunits,  small amounts of the  other  [3 
subunit can also be detected. 
Localization of the Na Constructs 
An Nc~ series of constructs was also made (see Fig. 2), in 
which  et-adaptin  sequence  is  followed  by  ~/-adaptin  se- 
quence in the NH2-terminal domain, which is in turn fol- 
lowed  by the  bovine ",/-adaptin hinge  and  the  ct-adaptin 
ear. This series was more difficult to study by immunopre- 
cipitation  because  only  small  amounts  of  protein  were 
The Journal of Cell Biology,  Volume 131, 1995  622 Figure 3. Immunofluorescence localization of the N-y series of constructs. Stably transfected cells were labeled with mAb 100/3, which 
recognizes the bovine ",/hinge and thus only labels the chimeric protein and not endogenous a-adaptin (a-c, g, and h). The cells were 
double labeled with a rabbit antibody against the c(-adaptin hinge, which only recognizes endogenous a-adaptin (d-f, i, and j). N'y-36 (a) 
and N'y-132 (b) are targeted to the plasma membrane, N~/-190 (c) is cytoplasmic, and N~/-331 (g) and N~-566 (h) are targeted primarily 
to the TGN although some plasma membrane labeling can also be seen, particularly in the cells expressing N~/-331 (arrowheads).  Bar, 
15 ~m. 
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bodies against the various subunits.  Strips were cut from blots of 
either plasma membrane adaptors (left) or TGN adaptors (right) 
and probed with antibodies raised against nonhomologous  stretches 
of sequence expressed as GST fusion proteins. The labeling shows 
that the antibodies are specific for the subunit against which they 
were raised.  The lower molecular mass band labeled with the an- 
tibody against  [3-adaptin  is  presumably  a  breakdown  product, 
since 13-adaptin is known to be susceptible  to proteolysis (Kirch- 
hausen et al., 1989). 
brought down, which appeared to be below the limit of de- 
tection for most of the antibodies.  However, the immuno- 
fluorescence results  shown in Fig. 6  reveal  a  very similar 
pattern to that seen for the N~/series. 
Na-132 (Fig. 6, a) is localized to the TGN, with consider- 
able cytoplasmic staining but no detectable  plasma mem- 
brane  staining  (d).  The  next  two chimeras  in this  series, 
Na-171 (b) and Na-265 (c), appear to be completely cyto- 
plasmic  with  no  recruitment  to  either  the  plasma  mem- 
brane (e and f) or the TGN. The last three chimeras, Nc~- 
350  (g),  Na-430  (h)  and Na-566  (i),  are  recruited  to the 
plasma  membrane  as  shown  by their  colocalization with 
endogenous et-adaptin  (j-l). Thus, there is again a stretch 
of ~200 amino acids, between 132 and 350, which appears 
to be responsible  for targeting the adaptors to the appro- 
priate  membrane,  and  chimeras  made  within  this  region 
do not associate with any membrane. 
Although the chimeras Na-350, N~-430, and N~-566 are 
recruited  to  the  plasma  membrane,  they  have  a  rather 
patchy distribution.  Not  every coated pit  and vesicle  de- 
tected  with  the  antibody  against  endogenous  a-adaptin 
contains the chimeric constructs,  and the regions of colo- 
calization generally occur at areas where linear arrays are 
observed rather than discrete dots. Furthermore,  endoge- 
nous c~-adaptin tends to be depleted from the patches con- 
taining  the  chimeras  (Fig.  6, arrowheads).  In particularly 
Figure 5.  Immunoprecipitation of adaptor complexes containing 
chimeric adaptins. Extracts from stably transfected cell lines  ex- 
pressing constructs in the N~/series,  nontransfected Rat 1 cells, 
and cell lines expressing a~c~ and ~'ya were immunoprecipitated 
with  mAbl00/3  under  nondenaturing  conditions.  The  samples 
were subjected to SDS PAGE, Western blotted, and probed with 
antibodies  against the plasma membrane adaptor subunits  [3-adap- 
tin, AP50, and AP17 (top); and against the TGN adaptor subunits 
13'-adaptin, AP47, and AP19 (bottom). In the blots probed for the 
medium chains AP50 and AP47, a  contaminating band of ~50 
kD can be seen that probably is the immunoglobulin heavy chain. 
The medium chains appear as sharper bands just below the con- 
taminant. The higher intensity of labeling of the subunits that co- 
precipitate with a~/o~ and ~/~ appears to be a reflection of the to- 
tal  amount  of  adaptor  complex  immunoprecipitated,  since 
Western  blotting with  an antibody against the ~/-adaptin  hinge 
also gave a stronger signal (not shown). 
highly expressing cells, such as those shown in Fig. 7, a and 
c (small arrowheads), there often appears to be less endog- 
enous a-adaptin in general than nonexpressing cells (large 
arrowheads). These observations suggest that the chimeras 
may  be  competing  with  endogenous  a-adaptin  for  the 
other  adaptor  subunits  and/or  for  docking  sites  on  the 
membrane. The linear arrays containing the chimeras tend 
to be concentrated at the cell periphery (Fig. 7, b  and d), 
suggesting  that  they  might  be  associated  with  adhesion 
plaques. However, double labeling with anti-talin revealed 
only limited colocalization (not shown). 
Effect of the Ear Domain on Targeting 
The  constructs  in  both  the  N-/  series  and  the  Nu  series 
Figure 6.  Immunofiuorescence localization of the Na series of constructs. Stably transfected cells were double labeled with mAb 100/3 
(a, b, c, g, h, and i) and the rabbit antibody against the a-adaptin hinge (d, e, f, j, k, and l). Nc~-132  (a and d) is targeted to the TGN, Nc~- 
171 (b and e) and Na-265 (c and f) are cytoplasmic, and Na-350 (g and j), Nc~-430 (h and k), and Na-566 (i and l) are targeted to the 
plasma membrane although the labeling is somewhat patchy. The arrowheads indicate regions of the cells where the construct is concen- 
trated while endogenous c~-adaptin is depleted. Bar, 15 Ixm. 
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350 and Na-566 from the Nct series, double labeled with mAbl00/ 
3 (a and b) and the rabbit antibody against the ct-adaptin  hinge (c 
and d).  The constructs are generally found in linear arrays and 
tend  to be  concentrated at  the  cell  periphery.  In some of the 
highly expressing cells (small arrowheads), endogenous a-adaptin 
labeling appears to be less intense than in the nonexpressing ceils 
(large arrowheads). Bar, 15 Ixm. 
generally support the view that the adaptor head contains 
the major targeting signal. However, one of the constructs, 
N~/-331,  although  primarily  targeted  to  the  TGN,  also 
shows a substantial amount of labeling at the plasma mem- 
brane.  To find out whether  this plasma membrane  local- 
ization  is  a  result  of  the  minor  targeting  signal  in  the 
et-adaptin ear, or whether there is another targeting signal 
between amino acid 331 and the hinge, an additional con- 
struct was made, N~/-331% in which the a  ear on N~/-331 
was replaced  with the ~/-adaptin  ear.  An equivalent  con- 
struct  was  also  made  from the  Na  series,  Net-350V  (see 
Fig. 2). 
Unlike N~-331 with the ct ear (Fig. 8, a  and c; see also 
Fig. 3), N~/-331~/is localized exclusively to the TGN (Fig. 
8, b and d). This indicates that the presence of the c~-adap- 
tin ear is solely responsible for the fraction of N~/-331  lo- 
calized to the plasma  membrane.  The localization of the 
reverse construct, Nu-350, is also influenced by its ear do- 
main. This construct has a patchy plasma membrane distri- 
bution when the ~t-adaptin ear is present  (Fig. 8, e  and g; 
see also Figs.  6  and 7).  However, with the ~-adaptin  ear, 
although much of the construct is cytoplasmic, some of it is 
recruited  to the TGN and no plasma membrane localiza- 
tion can be seen (Fig. 8,fand h). Thus, the ear has a much 
stronger  effect  on  targeting  when  placed  on  constructs 
containing a chimeric NHE-terminal domain. 
Figure 8.  Effect of the ear domain on targeting. Cells expressing 
the constructs N~-331 (a) and Na-350 (e) with the ot-adaptin ear, 
and cells expressing the same constructs but with the ~-adaptin 
ear,  N~-331~/ (b)  and  Na-350~/  (f),  were  double  labeled  with 
mAb 100/3 (a, b, e, and f) and the rabbit antibody against the 
u-adaptin hinge (c, d, g, and h). The presence of the ~/-adaptin ear 
results in more TGN labeling relative to plasma membrane label- 
ing. Bar, 15 p,m. 
Localization of fl-Adaptin 
Are the  13 subunits  redistributed  in cells expressing  some 
of  the  chimeras?  Because  the  antibody  raised  against 
13-adaptin was able to be used for immunofiuorescence, it 
was possible  to address  this  question  by double labeling. 
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were found to associate preferentially with  [3-adaptin al- 
though they are localized to the TGN, which suggests that 
some of the 13-adaptin  in these cells should also be detect- 
able at the TGN. Fig. 9 shows a mixture of transfected and 
nontransfected  cells double  labeled for the  construct  (a) 
and for [3-adaptin (b), and reveals that in the transfected 
cells, there is indeed a significant redistribution of [3-adap- 
tin to the TGN. 
Another  prediction  is that by analogy with the  N~ se- 
ries,  constructs  such  as  No~-350 in  the  Na  series  should 
preferentially  coassemble  with  [3'-adaptin  rather  than 
[3-adaptin.  Thus,  since  endogenous  a-adaptin  is  depleted 
from patches of coated pits containing the construct, [3-adap- 
tin should also be depleted. Fig. 9, c and d, shows that this 
is in fact the case. However, because as yet we have no ev- 
idence  that  the  construct  associates  with  [3'-adaptin,  we 
cannot  completely rule  out  the  possibility  that  adaptor 
complexes  assembled  from  this  construct  contain  no  13 
subunit of either type. 
Interactions between the Adaptor Subunits 
The results of the chimera experiments suggest that  the 
a- and ~/-adaptins interact both with the [3/[3'-adaptins and 
with the medium and/or small chains.  However, it is not 
possible using this method to show conclusively that two 
subunits bind to each other, because all of the adaptor sub- 
units are coexpressed within the same cell and interactions 
could be indirect. To investigate interactions between de- 
fined  pairs  of subunits,  we  made  use  of the  yeast  two- 
hybrid system, cDNAs encoding the various subunits were 
inserted  into  the  yeast  vectors  pGAD424  and  pGBT9. 
pGAD424 directs the expression of a transcriptional acti- 
vator fusion protein, while pGBT9 directs the expression 
of a  GAL 4  DNA binding  domain fusion protein.  If the 
two fusion proteins interact, the  transcriptional  activator 
domain is brought to the correct location to allow produc- 
tion of [3-galactosidase, which can be detected either by a 
plate assay or by a liquid culture assay. 
Table I shows the results of coexpressing different adap- 
tor subunits using this system. As predicted by the immu- 
noprecipitation experiments, [3- and [3'-adaptins were found 
to behave promiscuously, binding to subunits in both adap- 
tor complexes. Thus, [3-adaptin is able to interact not only 
with a~/a and with the plasma membrane adaptor medium 
chain AP50,  but  also with ~/-adaptin  (',/~/a and  ~/~'y) and 
with  AP47.  Similarly,  [3'-adaptin  associates  with  both 
plasma membrane and TGN adaptor et/~/subunits and me- 
dium chains.  No  interactions  could be detected  between 
the [3 subunits and the adaptor small chains. 
Constructs containing the o~- and -,/-adaptin NH2-termi- 
nal domains, cc,/c~ and "¥'ya, were found to bind both to the 
Figure 9.  Immunofluorescence  localization  of [3-adaptin  in  cells 
expressing  the  Na-350  (c  and d)  and N-y-566~/ (a  and b)  con- 
structs.  A  mixture of transfected and nontransfected cells were 
double labeled with mAbl00/3 (a and c) and an antibody against 
[3-adaptin (b and d). Expression  of the constructs  causes a redis- 
tribution  of [3-adaptin.  In  the  case  of the  N~x-350-expressing 
cells, [3-adaptin is partially  localized  to the TGN region.  In the 
case of the N3~-566"y-expressing  cells (small  arrowheads), [3-adap- 
tin  labeling  is less intense,  especially  in regions  containing  the 
construct,  than in nonexpressing cells (large arrowheads). Bar, 
15 tzm. 
Table I. The fl-Galactosidase Activities of  Adaptor Subunits in 
the Two-Hybrid System 
pGAD424  pGBT9  Colony  13-Galactosidase 
insert  insert  color  units 
13  None  White  0.00 
13  a~/o~*  Blue  38.56 
13  ~/21a  Blue  0.37 
13  ~/3,~/  Blue  0.52 
13  AP50  Blue  102.00 
13  AP47  Blue  25.35 
13  AP17  White  0.00 
13  AP19  White  0.00 
3'  None  White  0.08 
3'  a3,ot*  Blue  22.29 
3'  ~/3~et  Blue  1.41 
3'  ~/',/3~  Blue  1.45 
3'  AP50  Blue  20.08 
3'  AP47  Blue  18.65 
3'  AP 17  White  0.01 
3'  AP 19  White  0.03 
c~3~c~  None  White  0.01 
cx~  AP50  White  0.00 
cx~x  AP47  White  0.00 
~3~c~  AP17  Blue  1.32 
a~/a  AP19  White  0.01 
~/',/c~  None  White  0.01 
~/~a  AP50  White  0.02 
",/3~a  AP47  White  0.00 
~/"/a  AP 17  White  0.00 
",/~/a  AP 19  Blue  12.35 
Yeast strains were grown in SD media lacking leucine and tryptophan and 13-galactosi- 
dase assays were performed on at least two independent colonies. 
*a',/et in the yeast vector pGBT9 produces  a background  13-galactosidase activity of 
2.86 units. 
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though  apparently not  to the  medium chains,  nor could 
any  interactions  be  detected  between  the  medium  and 
small chains (not shown). In contrast to those interactions 
involving the 13 subunits, the interactions between a- and 
~-adaptins and the small chains are entirely complex-spe- 
cific.  Thus, a~c~ interacts with AP17  but not with AP19, 
while "V'Vc~  interacts with AP19 but not with AP17. 
Discussion 
Previous studies making use of ct- and ~/-adaptin chimeras 
have indicated  that  the  major targeting determinant  re- 
sides in the adaptor head rather than in the c~ and 3, hinge 
or ear domains  (Robinson,  1993).  The present study re- 
veals that a stretch of ~200 amino acids within the ct- and 
~-adaptin NH2-terminal domain is important for the tar- 
geting of adaptors to the  appropriate membrane. In the 
first series of constructs, the chimera N~/-132 was found to 
be recruited  to the plasma membrane while N~-331  was 
directed  primarily to  the  TGN, suggesting  that  residues 
132 to 331 are involved in targeting, but not residues 1-132 
and 331-600.  A  similar conclusion was reached from the 
reverse series of constructs, where a region between resi- 
dues 132 and 350 was found to be important. Any chimera 
made with a join between ct- and "y-adaptin within this 200 
amino acid stretch resulted in a cytoplasmic distribution, 
suggesting that this disrupted the targeting signal. 
However, these  findings  do not  necessarily mean that 
the 200-amino acid stretch itself contains the targeting sig- 
nal. The NHE-terminal domain of ct- and ~-adaptin is the 
part of the protein that interacts  with  the  other adaptor 
subunits, any one of which might contain targeting infor- 
mation, and an alternative explanation is that this stretch 
of sequence may be necessary for binding one or more of 
the  other proteins. Thus, the subunit  composition of the 
adaptor complexes assembled from the chimeric adaptins 
was determined. In the N'y series, essentially all of the con- 
structs were found to associate preferentially with [3-adap- 
tin  rather  than  with  13'-adaptin,  including  those  with  a 
TGN distribution.  Previous studies suggested but did not 
prove that the [3 subunits are not involved in adaptor local- 
ization. The present findings provide definitive evidence 
that ~3- and ~3'-adaptin do not contain any targeting infor- 
mation. 
In contrast, the medium and/or small chains are strong 
candidates for subunits containing targeting signals, since 
the chimeras N',/-36 and N~-132, which are targeted to the 
plasma membrane, were found to associate with AP50 and 
AP17, while N~/-331, N~-566, and N~-331% which are tar- 
geted either primarily or exclusively to the TGN, interact 
with AP47 and AP19. This correlation between the pres- 
ence of a particular medium and small chain and recruit- 
ment  onto  a  particular  membrane  suggests  that  one  or 
both of these subunits are likely to be involved in target- 
ing, although a role for a/-/-adaptin NHz-terminal sequence 
cannot be ruled out. 
Although  the  major  targeting  determinant  appears to 
reside in the adaptor head, the ~- and -/-adaptin ears also 
contribute to targeting. This possibility was suggested by 
the original ear swap experiments, but the contribution of 
the ears is more striking in the present study where differ- 
ent ears were placed on NH2-terminal domain chimeras. 
Thus, N-/-331 with the a  ear is found at the plasma mem- 
brane as well as at the TGN, while N'V-331 with the ~/ear 
(N'y-331",/) is found exclusively at the TGN; and Nc~-350 
with the ~ ear has a patchy plasma membrane distribution, 
while with the -/ear (Net-350-/) the membrane-associated 
fraction is found at the TGN. One possible explanation for 
these observations is that the ears may play a passive role 
in targeting,  promoting adaptor-adaptor interactions  and 
thus  causing  chimeric  adaptors  to  bind  to  a  particular 
membrane  through  interactions  with  endogenous  adap- 
tors.  However,  although  self-association  has  been  ob- 
served for plasma membrane adaptors in vitro (Beck and 
Keen, 1991), it seems to involve the head rather than the 
ear  domains,  and  no  such  self-association has  been  ob- 
served for TGN adaptors.  Alternatively, the ear domain 
might contain a weak but active targeting signal that takes 
over when a more dominant targeting signal is destroyed 
or weakened. This second possibility is supported by the 
observation that most of the NH2-terminal domain chime- 
ras appear to be impaired in their ability to associate with 
membranes, resulting  in  a  more cytoplasmic distribution 
than  that  observed  for  either  wild-type  or  ear-swapped 
adaptins. The fact that such chimeras, at least in the N-/se- 
ries, are still capable of interacting with the medium and 
small chains suggests that the a- and ",/-adaptin NH2-termi- 
nal domains may contain intrinsic targeting information. 
Although  most of the  chimeras showed  at least some 
membrane association,  those  made  with  a  join  between 
amino acids ,--d30 and 330-350 appeared to be completely 
cytoplasmic. This suggests either that such constructs are 
missing a  targeting signal in this region, or that they are 
unable to fold correctly and/or to coassemble with one or 
more of the other subunits. In the blot shown in Fig. 4 of 
the N'y series, none of the other subunits could be detected 
in the immunoprecipitate of the cytoplasmic construct N-,/- 
190, but this result must be interpreted with caution since 
the precipitate also contained relatively little of the con- 
struct itself. Attempts to label blots of immunoprecipitates 
from the supernatant/cytosol fraction rather than the pellet/ 
membrane fraction generally resulted in very high back- 
ground,  but  AP19  was clearly present  (not  shown),  and 
our inability to detect any of the other subunits unambigu- 
ously may simply be a reflection of the quality of the anti- 
bodies (the adaptor subunits  are very poor antigens  and 
these are the first such antibodies so far described). 
Three of the constructs in the Nc~ series, Net-350, Na- 
430,  and  Net-566,  had  an  unexpected  distribution:  they 
were  found  in  only  a  subset  of the  plasma  membrane 
coated pits, which tended to form linear arrays. This sort 
of linear pattern has also been observed in nontransfected 
cells, where the lines have been shown to correspond to 
stress fibers (Anderson et al., 1978), but in the transfected 
cells these linear arrays were often devoid of endogenous 
adaptors. The exclusion of endogenous adaptors from the 
coated pits containing  the  constructs  suggests that  some 
sort of competition might be occurring. For instance, the 
chimeric  adaptors  may compete with  endogenous  adap- 
tors for a  specific receptor or docking site,  or they may 
preferentially  self-associate.  Alternatively,  they  may  be 
impaired in their ability to cycle on and off the membrane 
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pits unable to pinch off as coated vesicles and/or to uncoat. 
As well as providing information about targeting signals, 
the construction of chimeras has also extended our knowl- 
edge of how the adaptor subunits interact with each other. 
Thus,  we  have  identified  amino  acids  132-331  as  a  se- 
quence  involved  in  the  binding  of  the  medium  and/or 
small chains,  since  the  construct  N-/-132  associates  with 
AP50 and AP17, while N~-331  associates with AP47 and 
AP19.  We have also identified  amino acids 566-594  as a 
sequence  involved in the binding  of the  13 subunit,  since 
N~-566 preferentially associates with 13-adaptin while ~',/a 
preferentially  associates  with  13'-adaptin.  Interestingly, 
this  sequence  is  immediately  downstream  from  an  11- 
amino acid sequence that is identical in c~- and ",/-adaptin. 
Possibly the two sequences together constitute an impor- 
tant part of the 13 binding domain, the first sequence being 
involved in general binding and the second sequence pro- 
viding some specificity. It is clear, however, that 13- and 13'- 
adaptin behave somewhat promiscuously. Immunoprecipi- 
tates not only of the NH2-terminal domain chimeras, but 
also of the constructs a~c~ and 2,~,a, and even of wild-type 
ct- and -/-adaptins in pig brain cytosol (not shown), show a 
certain amount of coprecipitation of the wrong 13 subunit. 
The yeast two-hybrid approach has allowed us to inves- 
tigate  interactions  between  adaptor  subunits  more  di- 
rectly, using a more defined system. We were able to con- 
firm that 13- and 13'-adaptin bind promiscuously, not only 
to c~- and ~/-adaptin but also to the adaptor medium chains. 
We were also able to demonstrate complex-specific inter- 
actions  between  the  a/-/ subunits  and  the  adaptor  small 
chains.  Thus,  we  can  now begin  to refine  the  schematic 
model shown in Fig. 1 to include specific protein-protein 
interactions.  An  earlier  study  making  use  of reversible 
cross-linkers  suggested  that  the  100-kD  proteins  (i.e., 
adaptins)  interact  with  both  the  medium  and  the  small 
chains, but at that time it was not possible to distinguish 
between  the  different  adaptins  (Virshup  and  Bennett, 
1988). More recently a model has been proposed, based on 
relative sequence homologies, in which the 13 subunits bind 
to the small chains while the a/~ subunits bind to the me- 
dium  chains  (Nakayama et  al.,  1991).  Our  results  show 
that in fact the opposite is the case. However, we cannot 
rule out the possibility that that there may be additional 
interactions  that  cannot  be  not  detected  using  the  two- 
hybrid system due to conformational differences between 
isolated subunits and the adaptor complex as a whole. In- 
deed,  it  seems likely  that  the  medium  and  small  chains 
must interact with each other to account for our immuno- 
precipitation results, since AP50 was always found to be 
coincident with AP17, and AP47 with AP19. 
In conclusion, our results show that there must be more 
than one targeting signal in the adaptor complex. The 13 
subunits, which are to some extent interchangeable, can be 
ruled out; but the et- and ",/-adaptin ears play more of a role 
in  targeting  than  was previously suspected,  and  there  is 
also a targeting signal in the head that is likely to involve 
the  medium  and/or  small  chains,  and  possibly  also  the 
NHe-terminal domains of the c~- and ~/-adaptins. These find- 
ings  can be correlated with studies  on adaptor targeting 
making use of in vitro reconstitution  systems. It is clear 
from such studies that adaptor recruitment is not a simple 
binding  event. Energy is required,  and there is evidence 
that members of the ARF family of proteins are involved, 
possibly by activating the putative docking proteins (Rob- 
inson  and  Kreis,  1992;  Traub  et  al.,  1993;  Stamnes  and 
Rothman, 1993; Seaman et al., 1993). Membrane proteins 
known to be concentrated in clathrin-coated pits and vesi- 
cles, such as the mannose-6-phosphate receptor, are also 
likely to play a role (Le Borgne et al., 1993). Recent cross- 
linking experiments suggest that the docking proteins may 
consist of more than one subunit (Seaman, 1995;  Seaman 
and Robinson, unpublished observations). Thus, it is pos- 
sible that different targeting signals on the adaptor com- 
plexes interact with different components of the cellular 
machinery  involved  in  adaptor  recruitment.  The  yeast 
two-hybrid system has the potential to be used not only to 
investigate interactions  between known proteins  such  as 
neighboring  adaptor  subunits,  but  also  to  look  for  un- 
known binding partners. We are currently using this method 
to try to identify novel proteins that interact with each of 
the adaptor subunits. 
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